Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. EuroPCR 2016 Update: TAVR innovations, FFR systems in the spotlight
St. Jude Medical announced it won CE Mark approval in the European Union for its PressureWire X Guidewire fractional flow reserve measurement system and is launching the product in Europe.
The company announced the launch and clearance at the EuroPCR meeting in Paris this week. Read more
4. Report: Medical device recalls hit 3-year low in Q1
Medical device recalls fell to their lowest point since 2013 during the 1st quarter, according to a report from Stericycle‘s ExpertSolutions business.
Both the number of recalled units and the actual number of recalls hit 3-year lows, coming in at 30% below their 2-year quarterly averages, according to the report. Read more
3. Endo’s AMS claims pelvic mesh plaintiffs scammed into needless explantation surgeries
Endo International subsidiary American Medical Systems Holdings repoortedly accused “a pyramid of businessmen, doctors and lawyers” of convincing women to undergo unnecessary surgeries to remove pelvic mesh implants and inflate their damage claims.
AMS has set aside $1.9 billion to cover as many as 49,000 product liability lawsuits alleging injury from the devices. But the company claims it’s found at least 4 instances of women undergoing explantation procedures their own doctor’s didn’t recommend, funded by a lender working with the explanting surgeons. The company alleged in a court filing that hundreds more have been influenced to have the surgeries by a network of lenders, doctors and attorneys “orchestrating the exploitation of unsophisticated medical and legal consumers and seeking to perpetrate a fraud,” according to Reuters. Read more
2. Johnson & Johnson’s robotics unit Verb Surgical aims for end-of-year unveiling
Johnson & Johnson expects its Verb Surgical robot-assisted surgery business to move from concept to product design by the end of the year, company officials said this week as they updated investors on their plans for the world’s largest medical device business.
Gary Pruden, chairman of J&J’s $25.1 billion medical device division, said Verb Surgical expects to log “an important milestone at the end of the year, when we transition from concept development to full product development,” adding that more details on the system’s design would be revealed at that point. Read more
1. Jury awards Edwards Lifesciences $70m in CardiAQ Valve spat with Neovasc
A federal jury in Massachusetts yesterday awarded $70 million to Edwards Lifesciences subsidiary CardiAQ Valve Technologies in a patent infringement lawsuit after finding that Neovasc stole trade secrets and breached a non-disclosure agreement.
The lawsuit, filed in June 2014 in the U.S. District Court for Massachusetts, accused Neovasc of using the misappropriated trade secrets to develop its Tiara transcatheter mitral valve replacement. Edwards inherited the lawsuit when it acquired CardiAQ Valve for $400 million in August 2014. Read more
The post MassDevice.com +5 | The top 5 medtech stories for May 20, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1U4kxyR
Cap comentari:
Publica un comentari a l'entrada